- Category
- Micro (2023-24)
- Udyam number
- UDYAM-AS-03-0028740

Biomed Polyclinic LLP
About Biomed Polyclinic LLP
Data last updated:
Biomed Polyclinic LLP is a limited liability partnership (LLP) based in Guwahati, Assam, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 10 July 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Guwahati, under LLPIN AAS-8359.
The LLP has a total obligation of contribution of ₹5 Cr. It is led by designated partners Dopati Paul and Ranabir Paul.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Guwahati, Assam.
As per MCA filings, the LLP has open charges of ₹15.78 Cr on record.
Biomed Polyclinic LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-03-0028740).
Company details
Recognitions & Rankings of Biomed Polyclinic
Contact details
Biomed Polyclinic LLP's registered office is in Guwahati, Assam.
- Registered AddressHouse No. 398 Dag No. 537 Of K.P. Patta No. 110 Second Floor Prabir Market Paltan Baza, R, Guwahati, Assam, India – 781008
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Biomed Polyclinic LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Biomed Polyclinic LLP, buy the company report.
Designated partners of Biomed Polyclinic LLP
Biomed Polyclinic has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dopati Paul | Designated Partner | 10 Jul 2020 | 6 Years 3 Months | Current |
| Ranabir Paul | Designated Partner | 10 Jul 2020 | 6 Years 3 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jan 2023 | 100681679 | Siemens Financial Services Private Limited | ₹6.48 Cr | Open | |
| 15 Mar 2021 | 100469557 | North Eastern Development Finance Corporation Limited | ₹9.3 Cr | Open |
To see the full charge records of Biomed Polyclinic LLP, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Biomed Polyclinic LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biomed Polyclinic LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biomed Polyclinic LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biomed Polyclinic LLP has 2 designated partner changes on record since 2020: 2 appointments. The latest: Dopati Paul was appointed as Designated Partner on 10 Jul 2020.
Frequently asked questions
Biomed Polyclinic is an active limited liability partnership based in Guwahati, Assam, India. The LLP works in hospitals, within the healthcare industry. It was incorporated on 10 July 2020 (6+ years old) and is registered under LLPIN AAS-8359.
Biomed Polyclinic has 2 current designated partners:
- Dopati Paul - Designated Partner
- Ranabir Paul - Designated Partner
The latest financial statements of Biomed Polyclinic on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Biomed Polyclinic is AAS-8359. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Biomed Polyclinic was incorporated on 10 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Guwahati.
Dopati Paul was appointed as Designated Partner on 10 Jul 2020. Ranabir Paul was appointed as Designated Partner on 10 Jul 2020.
Yes, Biomed Polyclinic is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-03-0028740).
The registered office of Biomed Polyclinic is at House No. 398 Dag No. 537 Of K.P. Patta No. 110 Second Floor Prabir Market Paltan Baza, R, Guwahati, Assam, India – 781008.
Biomed Polyclinic operates in the healthcare industry, in the hospitals segment.
Biomed Polyclinic has open charges of ₹15.78 Cr and no satisfied charges on record as per latest MCA filings.